Tag Archives: Albireo Pharma Inc

Albireo Pharma Inc (ALBO) Receives a Rating Update from a Top Analyst

Cowen & Co. analyst Ritu Baral maintained a Buy rating on Albireo Pharma Inc (ALBO – Research Report) yesterday. The company’s shares closed yesterday at $25. According to TipRanks.com, Baral is a top 100 analyst with an average return of

Albireo Pharma Inc (ALBO) Receives a Buy from Needham

Needham analyst Alan Carr maintained a Buy rating on Albireo Pharma Inc (ALBO – Research Report) today and set a price target of $50. The company’s shares opened today at $24.94. Carr observed: “Albireo provided a quarterly corporate update today

Wedbush Sticks to Its Buy Rating for Albireo Pharma Inc (ALBO)

In a report released today, Liana Moussatos from Wedbush reiterated a Buy rating on Albireo Pharma Inc (NASDAQ: ALBO), with a price target of $69. The company’s shares opened today at $28.93. According to TipRanks.com, Moussatos is ranked 0 out

Albireo Pharma Inc (ALBO) Receives a Buy from Cowen & Co.

In a report released today, Ritu Baral from Cowen & Co. maintained a Buy rating on Albireo Pharma Inc (NASDAQ: ALBO). The company’s shares opened today at $29.47. According to TipRanks.com, Baral is a top 100 analyst with an average

Roth Capital Reiterates Their Buy Rating on Albireo Pharma Inc

In a report issued on May 18, Yasmeen Rahimi from Roth Capital reiterated a Buy rating on Albireo Pharma Inc (NASDAQ: ALBO), with a price target of $86. The company’s shares closed on Friday at $32.86. According to TipRanks.com, Rahimi

Albireo Pharma Inc Received its Third Buy in a Row

After Jefferies and Wedbush gave Albireo Pharma Inc (NASDAQ: ALBO) a Buy rating last month, the company received another Buy, this time from Needham. Analyst Alan Carr assigned a Buy rating to Albireo Pharma Inc today and set a price